New Derivatives of Amphotericin B and Nystatin A1: Effects on Fungal Activity and Toxicity
Author Information
Author(s): Olga Omelchuk, Elena Bychkova, Svetlana Efimova, Natalia Grammatikova, George Zatonsky, Lyubov Dezhenkova, Svetlana Solovieva, Olga Ostroumova, Anna Tevyashova, Andrey Shchekotikhin
Primary Institution: Gause Institute of New Antibiotics, Moscow, Russia
Hypothesis
Can new N-alkylated derivatives of amphotericin B and nystatin A1 improve antifungal activity while reducing toxicity?
Conclusion
The mono-N-alkylated compound 3 showed the best activity-toxicity ratio, indicating potential for further development.
Supporting Evidence
- Derivatives containing the N-(hydroxyethyl)amino)ethyl fragment exhibited high antifungal activity.
- Mono-N-alkylated compound 3 showed the highest activity/toxicity ratio.
- Combining two successful modifications did not improve the activity/toxicity ratio.
Takeaway
Scientists are trying to make better antifungal medicines by changing the structure of existing drugs to make them work better and hurt people less.
Methodology
The study synthesized N-alkylated derivatives and tested their antifungal activity against various Candida strains and Aspergillus fumigatus using broth microdilution, along with cytotoxicity assays on human cells.
Limitations
The study primarily focused on in vitro results, which may not fully predict in vivo efficacy and safety.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website